Quick Listen: Scrip’s Five Must-Know Things
Executive Summary
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.
This episode looks at the big stories as reported by Scrip's global team for the business week ended 27 November 2020.
On the menu this time are further developments with coronavirus vaccines, big pharma efforts to showcase and continue R&D amid the pandemic, and an alliance change in the cardiovascular area.
Stories mentioned in this episode:
(Also see "A Stroke Of Luck Boosts Oxford/AZ’s “Vaccine For The World”" - Scrip, 24 Nov, 2020.)
(Also see "Novartis CEO Touts R&D 'Wild Cards' As Proof Of Deep Pipeline" - Scrip, 25 Nov, 2020.)
(Also see "Sanofi Grapples With Pandemic, Growing Clinical Trials, Implementing Acquisitions" - Scrip, 24 Nov, 2020.)
(Also see "Amgen Hands Omecamtiv Back To Cytokinetics" - Scrip, 23 Nov, 2020.)
(Also see "Pfizer And Moderna’s Cold War On COVID Gets Competitive" - Scrip, 19 Nov, 2020.)
These and all Informa Pharma Intelligence podcasts are available on SoundCloud, Apple Podcasts, TuneIn and Google Play and also via smart speakers - just make sure one of these providers is set up as your default for podcasts, and then ask for "Pharma Intelligence podcasts".